Through two distinct protocols, conditional CD11c+ systemic depletion and conditional CD11c+ local depletion via DTx administration, we investigated the impact on bleomycin‐induced pulmonary fibrosis. The gene discussed is ITGAX; the disease is pulmonary fibrosis.